How grapefruit juice potentiates drug bioavailability

Area of Science:

• Pharmacology
• Drug Metabolism
• Gastrointestinal Physiology

Background:

• Cytochrome P450 enzymes, particularly in the small intestine, play a crucial role in drug metabolism.
• Many common medications are substrates for these enzymes, influencing their efficacy and safety.
• Dietary components can interact with these enzymes, leading to significant pharmacokinetic changes.

Purpose of the Study:

• To investigate the interaction between grapefruit juice and commonly used medications.
• To elucidate the mechanism by which grapefruit juice affects drug bioavailability.
• To identify the specific enzyme systems involved in this interaction.

Main Methods:

• The study focused on the selective down-regulation of a specific subfamily of cytochrome P450 enzymes.
• Bioavailability of select medications was assessed following co-administration with grapefruit juice.
• Enzyme activity in the small intestine was measured to determine the extent of down-regulation.

Main Results:

• Grapefruit juice was found to significantly enhance the therapeutic effect of certain medications.
• This enhancement was directly correlated with increased drug bioavailability.
• The mechanism involved the selective down-regulation of a specific cytochrome P450 enzyme subfamily in the intestinal wall.

Conclusions:

• Grapefruit juice consumption can alter the pharmacokinetics of various medications.
• The observed effect is mediated by the inhibition of intestinal cytochrome P450 enzymes.
• Patients should be aware of potential drug-grapefruit interactions to optimize medication therapy.